Advertisement

Organisation › Details
Eurofins (Group)
Eurofins Scientific through its subsidiaries (hereinafter sometimes “Eurofins” or “the Group”) believes it is the world leader in food, environment and pharmaceutical products testing and that it is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. With over 27,000 staff in 310 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff. Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods. As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world. The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP). *
![]() |
Start | 1987-01-01 established |
![]() |
Industry | food analysis (food testing) |
Industry 2 | analytical services | |
![]() |
Person | Martin, Gilles G. (Eurofins 200701 CEO + founder) |
Street | 455 Chaussée de Malines | |
City | 1950 Kraainem | |
Tel | +32-2-766-1620 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | H: 10,001 to 50,00 (2019-12-31) |
Currency | EUR | |
Annual sales | 4,562,800,000 (revenues, consolidated (2019) 2019-12-31) | |
Profit | 195,300,000 (2019-12-31) | |
Cash | 297,000,000 (2019-12-31) | |
* Document for »About Section«: | ||
Record changed: 2025-03-16 |
Advertisement

More documents for Eurofins (Group)
- [1] SGS S.A.. (12/18/23). "Press Release: SGS Signs Agreement to Divest Crop Science Operations to Eurofins Scientific [ Ad hoc announcement pursuant to Art. 53 LR ] "....
- [2] Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg....
- [3] Berkeley Lights, Inc.. (3/9/22). "Press Release: Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer". Emeryville, CA....
- [4] Waters Corporation. (11/2/20). "Press Release: Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact Radian ASAP System". Milford, MA....
- [5] Eurofins Scientific. (4/16/20). "Press Release: Eurofins Genomics Launches »SARS-CoV-2 Full-length Genome Sequencing« Service to Support Researchers Globally in Their Fight against the COVID-19 Pandemic and Outbreak Source Tracing". Ebersberg....
- [6] Eurofins Genomics LLC. (8/6/19). "Press Release: Eurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron Biotech". Louisville, KY....
- [7] Eurofins Scientific. (6/25/19). "Press Release: Eurofins Expands Its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.". Luxembourg....
- [8] Eurofins Scientific. (6/24/19). "Press Release: Operations Returning to Normal After the Cyber Attack Announced on June 3, 2019". Luxembourg....
- [9] Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top